Distal femoral bone mineral density after Richards type II patellofemoral arthroplasty for isolated patellofemoral osteoarthritis: a 1-year follow-up study

Distal femoral bone mineral density after Richards type II patellofemoral arthroplasty for isolated patellofemoral osteoarthritis: a 1-year follow-up study - BMD after patellofemoral arthroplasty

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30609

Enrollment

Registered

2007-12-19

Start date

2008-01-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disuse osteoporosis periprosthetic bone resorption

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Not applicable

Exclusion criteria

Exclusion criteria: Patients with rheumatic, renal, hepatic or gastrointestinal disease, and patients using medication that interferes with mineral metabolism (i.e. treatment for osteoporosis or long-term steroid therapy). Previous total knee arthroplasty or patellofemoral arthroplasty of the contralateral knee.

Design outcomes

Primary

Measure	Time frame
BMD (g/cm2) of the periprosthetic distal femur and contralateral (non-operated) knee before patellofemoral arthroplasty, directly after, and 12 months after arthroplasty.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results